Physician profile
Basil Kurdali
NPI 1255570925
$3,656.84
in general payments reported to CMS, 2019-2025
11 companies · $655 in 2025
The $655 reported for 2025 was more than what 83% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $625 · 2020: $270 · 2021: $244 · 2022: $431 · 2023: $794 · 2024: $638 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,044 · Entertainment: $43.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,043.88 |
| Entertainment | $43.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,519.15 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Biotronik Nro, INC. | $558.76 | 2023-2025 | Prospera, Biotronik |
| Medtronic, INC. | $433.34 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Vertos Medical, INC. | $367.21 | 2022 | |
| Medtronic USA, INC. | $299.92 | 2019-2020 | |
| Mml US, INC. | $143.39 | 2023 | Reactiv8 |
| Relievant Medsystems, INC. | $125.84 | 2019 | |
| Vertiflex, INC. | $119.38 | 2019 | |
| Foundation Fusion Solutions, LLC | $43.10 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $29.75 | 2025 | |
| Fidia Pharma USA INC. | $17.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basil Kurdali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.